Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENWN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,579
Award facts
- Contract value 100% obligated
- $1,579.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $1,579.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. This delivery order, awarded on October 21, 2025, with an ultimate completion date of October 23, 2025, utilizes a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group was selected as a regional prime vendor contractor under the broader $30.3 billion PPV-G GEN V acquisition strategy, positioning it as a critical supplier for Department of Defense pharmaceutical and medical supply needs.
DMS Pharmaceutical Group's comprehensive product portfolio includes branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals serving military healthcare facilities worldwide. The company holds a single-award indefinite delivery contract (IDC) under PPV-G GEN V designated as contract SPE2DR, with a $499,999,999 ceiling and an ultimate completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. The vendor's established performance across numerous delivery orders demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FENWN?
SPE2DU26FENWN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DU26FENWN worth?
The government has obligated $1,579 on SPE2DU26FENWN.
Is contract SPE2DU26FENWN an order under another contract?
Yes. SPE2DU26FENWN is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENWN competed?
The extent of competition for SPE2DU26FENWN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award